Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 11/20 | 0.60 |
| ▸ | UGCG | Q16739 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MC3R | P41968 | 3/20 | 0.44 |
| ▸ | HRH2 | P25021 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | MC5R | P33032 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6739687 | 0.86 | MC4R (0.60) | MC4RUGCGCYP3A4KMT2AMC3R | |
| SCHEMBL6739684 | 0.86 | MC4R (0.60) | MC4RUGCGCYP3A4KMT2AMC3R | |
| SCHEMBL6739689 | 0.86 | MC4R (0.60) | MC4RUGCGCYP3A4KMT2AMC3R | |
| SCHEMBL16825980 | 0.86 | MC4R (0.69) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6738398 | 0.83 | MC4R (0.58) | MC4RUGCGCYP3A4KMT2AMC3R | |
| SCHEMBL6738395 | 0.83 | MC4R (0.58) | MC4RUGCGCYP3A4KMT2AMC3R | |
| SCHEMBL6730396 | 0.82 | MC4R (0.59) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6730395 | 0.82 | MC4R (0.59) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL21674357 | 0.81 | MC4R (0.66) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL16846207 | 0.81 | MC4R (0.66) | MC4RUGCGCYP3A4MC3RMC5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004058735-A2 | LIGANDS OF MELANOCORTIN RECEPTORS AND COMPOSITIONS AND METHODS RELATED THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2004-07-15 | — | — | WO | disclosed |